Authors: NICOLAIDES C FOUNTZILAS G ZOUMBOS N SKARLOS D KOSMIDIS P PECTASIDES D KARABELIS A GIANNAKAKIS T SYMEONIDIS A PAPADOPOULOS A ANTONIOU F PAVLIDIS N

Citation: C. Nicolaides et al., DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 55(5), 1998, pp. 405-415

Authors: KOSMIDIS P MYLONAKIS N FOUNTZILAS G PAVLIDIS N SAMANTAS E KARABELIS A KATTIS K SKARLOS D

Citation: P. Kosmidis et al., A PROSPECTIVE RANDOMIZED PHASE-III STUDY IN NON-SMALL-CELL LUNG-CANCER COMPARING CISPLATIN, IFOSFAMIDE, VINBLASTINE (VIP) VERSUS CISPLATIN,IFOSFAMIDE AND ETOPOSIDE (VIP-16), Annals of oncology, 7(5), 1996, pp. 517-520

Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C KARVOUNIS N KORDOSSIS T DALIANI D KARABELIS A KOSMIDIS P

Citation: N. Tsavaris et al., USE OF NAPROXEN IN AMELIORATING INDUCED PARANEOPLASTIC FEVER, Clinical drug investigation, 10(1), 1995, pp. 8-11

Authors: TSAVARIS N CHARALAMBIDIS G PAGOU M KARABELIS A MYLONAKIS N BACOYIANNIS C KOSMIDIS P

Citation: N. Tsavaris et al., COMPARISON OF ONDANSENTRON (GR 3X032F) VERSUS ONDANSENTRON PLUS ALPRAZOLAM AS ANTIEMETIC PROPHYLAXIS DURING CISPLATIN-CONTAINING CHEMOTHERAPY, American journal of clinical oncology, 17(6), 1994, pp. 516-521

Authors: TSAVARIS N MYLONAKIS N BACOYIANNIS C TSOUTSOS H KARABELIS A KOSMIDIS P

Citation: N. Tsavaris et al., TREATMENT OF RENAL-CELL CARCINOMA WITH ESCALATING DOSES OF ALPHA-INTERFERON, Chemotherapy, 39(5), 1993, pp. 361-366